Dr. Justin Elijah Trivax, MD

Dr. Trivax practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Trivax's NPI, 1174566095, was assigned on June 14, 2006. Dr. Trivax graduated from Wayne State University School of Medicine in 2003. Dr. Trivax holds Michigan license 4301081886.

Dr. Trivax's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Trivax's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Trivax is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Michigan Healthcare Professionals, P.C. Dmand AI also links Dr. Trivax to 2 more hospitals, 5 medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trivax practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Trivax's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Trivax is board certified in interventional cardiology by the American Board of Internal Medicine. Dr. Trivax is licensed in Michigan.

CMS data shows 5,689 Medicare services from Dr. Trivax across 31 procedure codes in 2024, for 1,536 Medicare patients. Medicare paid $434,241 for them.

CMS counts 1,536 Medicare patients who saw Dr. Trivax in 2024. The largest group is 75 to 84, with 647 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Trivax's median patient age at 74, with 45% women.

In 2024, Dr. Trivax wrote 10,167 Medicare Part D claims for 1,560 patients. 79% of them were for generic drugs. CMS names the drug for 9,794 of them, across 75 drugs with 11 or more claims each, at $2,587,862 in total drug cost. In 2023, CMS named 8,728 claims across 75 drugs.

Dr. Trivax accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of coronary angioplasty and stenting by Dr. Trivax, more than 61% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Trivax, published from 2011 to 2020. 2012 was the busiest year, with 2. The most frequent topics are Cardiac Catheterization, Cardiovascular Diseases and Coronary Angiography. Dr. Trivax has published most often in Catheter Cardiovasc Interv. Dr. Trivax's most frequent co-authors are Robert D. Safian, MD, George S. Hanzel, MD and Amr E. Abbas, MD.

CMS Open Payments shows 1,347 general payments to Dr. Trivax from 68 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 84% of the total. Novartis Pharmaceuticals Corporation paid the most, $123,973.

Dr. Trivax graduated from Wayne State University School of Medicine in 2003.